Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Kathleen E. McGinness's research focuses on developing targeted therapies, particularly for cancer. Her work has investigated CAR T-cell therapies, exploring how modifications like exogenous GOT2 expression can enhance T-cell metabolism and improve anti-tumor activity against cell line-derived xenografts. She has also explored strategies to mitigate treatment-related toxicities, such as using geranylgeranyl transferase inhibitors to address intestinal radiation toxicity. McGinness's scholarship metrics include an h-index of 14, with 31 total publications and over 1,000 citations. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Rupak Pathak, Ruofei Du, Enoch K. Larrey, and H. Terence Cook, on shared publications.
Metrics
- h-index: 14
- Publications: 31
- Citations: 1,014
Selected Publications
-
Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity (2025)
Collaboration Network
Top Collaborators
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
Similar Researchers
Based on overlapping research topics